Trial Details

COMPLETED
Basic Information
Clinical ID c1004
Identifier NCT02620046
Trial Title A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Colitis, Ulcerative|Crohn's Disease
Interventions DRUG: Vedolizumab SC
Participant Information
Sponsor Takeda
City Phoenix
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2016-04-15
Primary Completion Date 2024-06-12
Completion Date 2024-06-12